Chronic renal failure natural history: Difference between revisions

Jump to navigation Jump to search
Line 61: Line 61:
|-
|-
|}
|}
==Stages of Chronic Kidney Diseases==
The stages of CKD is based on the GFR and other renal function abnormalities. The different stages of chronic kidney diseases are as follow:
* '''Stage 1''': GFR>90 ml/min/1.73m2 and evidence of kidney damage
* '''Stage 2''': GFR 60-89 ml/min/1.73m2 and evidence of kidney damage
* '''Stage 3''': GFR 30-59 ml/min/1.73m2
* '''Stage 4''': GFR 15-29 ml/min/1.73m2
* '''Stage 5''': GFR <15 ml/min/1.73m2


== ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT) <ref name="pmid16935995">{{cite journal| author=Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al.| title=ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. | journal=Circulation | year= 2006 | volume= 114 | issue= 10 | pages= e385-484 | pmid=16935995 | doi=10.1161/CIRCULATIONAHA.106.178233 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16935995}}</ref> ==
== ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT) <ref name="pmid16935995">{{cite journal| author=Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al.| title=ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. | journal=Circulation | year= 2006 | volume= 114 | issue= 10 | pages= e385-484 | pmid=16935995 | doi=10.1161/CIRCULATIONAHA.106.178233 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16935995}}</ref> ==

Revision as of 10:39, 27 November 2012

Chronic renal failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic renal failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic renal failure natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic renal failure natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic renal failure natural history

CDC on Chronic renal failure natural history

Chronic renal failure natural history in the news

Blogs on Chronic renal failure natural history

Directions to Hospitals Treating Chronic renal failure

Risk calculators and risk factors for Chronic renal failure natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

Chronic renal failure can be complicated by the development of disorders such as hyperuricemia, myopathy, congestive heart failure, pallor, nausea, anorexia, and peptic ulcers amongst other disorders. The prognosis of the disease is poor if mismanaged. If untreated, chronic renal failure (CRF) will progress to end-stage renal disease, which has a high morbidity rate.

Natural History

  • Inadequately controlled diabetes and hypertension increase the risk of progression of chronic kidney disease to end stage renal failure.
  • Repeated episodes of acute renal injury from infections, drugs, toxins and immunological damage, may accelerate the progression to chronic renal failure, especially in the elderly.
  • Even though renal failure is more common in women, the rate of progression of the disease is four times more faster in men than in women.

Complications

Improves with optimal program of dialysis and related therapy Persists or worsens after optimal program of dialysis and related therapy Develops after initiation of dialysis therapy
Fluid and Electrolytes Volume expansion, Hyponatremia, Hyperkalemia, Hyperphosphatemia
Endocrine-Metabolic disturbances Secondary hyperparathyroidism, Vitamin-D deficient osteomalacia, Carbohydrate resistance, Hyperuricemia, Hypertriglyceridemia, Protein-energy malnutrition, Amenorrhea Secondary hyperparathyroidism, Hyperuricemia, Hypertriglyceridemia, Increased lipoprotein (a) levels, Decreased HDL levels, Protein-energy malnutrition, Impaired growth and development, Infertility, Sexual dysfunction, Amenorrhea, Beta-2 microglobulin associated amyloidosis Adynamic bone, Beta-2 microglobulin associated amyloidosis
Neuromuscular disturbances Fatigue, Impaired mentation, Lethargy, Asterixis, Peripheral neuropathy, Restless leg syndrome, Myoclonus, Seizures, Coma Sleep disorders, Headache, Peripheral neuropathy, Restless leg syndrome, Seizures, Muscle cramps, Myopathy Muscle cramps, Myopathy
Cardiovacsular and Pulmonary Systemic hypertension, Congestive heart failure, Pulmonary edema, Pericarditis, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Uremic lung Systemic hypertension, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Accelerated atherosclerosis Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Accelerated atherosclerosis, Hypotension and arrhythmias
Dermatology Pallor, Hyperpigmentation, Ecchymoses, Uremic frost Pruritis, Hyperpigmentation Hyperpigmentation, Nephrogenic fibrosing dermopathy
Gastro-intestinal disturbances Anorexia, Nausea and vomiting, Gastroenteritis, Peptic ulcer, Gastrointestinal bleeding Peptic ulcer, Gastrointestinal bleeding Gastrointestinal bleeding, Idiopathic ascites, Peritonitis
Hematologic and immunologic disturbances Anemia, Bleeding diathesis, Increased susceptibility to infections Lymphocytopenia, Increased susceptibility to infections Bleeding diathesis, Leukopenia, Thrombocytopenia

Stages of Chronic Kidney Diseases

The stages of CKD is based on the GFR and other renal function abnormalities. The different stages of chronic kidney diseases are as follow:

  • Stage 1: GFR>90 ml/min/1.73m2 and evidence of kidney damage
  • Stage 2: GFR 60-89 ml/min/1.73m2 and evidence of kidney damage
  • Stage 3: GFR 30-59 ml/min/1.73m2
  • Stage 4: GFR 15-29 ml/min/1.73m2
  • Stage 5: GFR <15 ml/min/1.73m2

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT) [1]

Recommendations for End-Stage Renal Failure

Class I
"1. The acute management of ventricular arrhythmias in end-stage renal failure should immediately address hemodynamic status and electrolyte (potassium, magnesium, and calcium) imbalance. (Level of Evidence: C)"
"2. Life-threatening ventricular arrhythmias, especially in patients awaiting renal transplantation, should be treated conventionally, including the use of ICD and pacemaker as required, in patients who are receiving chronic optimal medical therapy and who have reasonable expectation of survival with a good functional status for more than 1 y. (Level of Evidence: C)"

Prognosis

The prognosis of patients with chronic kidney disease is guarded as epidemiological data has shown that all cause mortality (the overall death rate) increases as kidney function decreases.[2] The leading cause of death in patients with chronic kidney disease is cardiovascular disease, regardless of whether there is progression to ESRD.[2][3][4]

While renal replacement therapies can maintain patients indefinitely and prolong life, the quality of life of the patient is severely affected.[5][6] Renal transplantation increases the survival of patients with ESRD significantly when compared to other therapeutic options;[7][8] however, it is associated with an increased short-term mortality (due to complications of the surgery). Transplantation aside, high intensity home hemodialysis appears to be associated with improved survival and a greater quality of life when compared to the conventional thrice weekly hemodialysis and peritoneal dialysis.[9]

References

  1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M; et al. (2006). "ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation. 114 (10): e385–484. doi:10.1161/CIRCULATIONAHA.106.178233. PMID 16935995.
  2. 2.0 2.1 Perazella MA, Khan S. Increased mortality in chronic kidney disease: a call to action. Am J Med Sci. 2006 Mar;331(3):150-3. PMID 16538076.
  3. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003 Oct 28;108(17):2154-69. PMID 14581387. Free Full Text.
  4. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX. Chronic Kidney Disease and Mortality Risk: A Systematic Review. J Am Soc Nephrol. 2006 May 31; PMID 16738019.
  5. Heidenheim AP, Kooistra MP, Lindsay RM. Quality of life. Contrib Nephrol. 2004;145:99-105. PMID 15496796.
  6. de Francisco AL, Pinera C. Challenges and future of renal replacement therapy. Hemodial Int. 2006 Jan;10 Suppl 1:S19-23. PMID 16441862.
  7. Groothoff JW. Long-term outcomes of children with end-stage renal disease. Pediatr Nephrol. 2005 Jul;20(7):849-53. Epub 2005 Apr 15. PMID 15834618.
  8. Giri M. Choice of renal replacement therapy in patients with diabetic end stage renal disease. EDTNA ERCA J. 2004 Jul-Sep;30(3):138-42. PMID 15715116.
  9. Pierratos A, McFarlane P, Chan CT. Quotidian dialysis--update 2005. Curr Opin Nephrol Hypertens. 2005 Mar;14(2):119-24. PMID 15687837.


Template:WH Template:WS